(±)-Acetylcarnitine chloride
CAS No. 2504-11-2
(±)-Acetylcarnitine chloride( —— )
Catalog No. M33752 CAS No. 2504-11-2
(±)-Acetylcarnitine chloride (Acetyl dl-carnitine chloride) is a weak cholinergic agonist with neuroprotective properties and can be used in studies of neuritis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | Get Quote |
|
| 10MG | 34 | Get Quote |
|
| 25MG | 52 | Get Quote |
|
| 50MG | 75 | Get Quote |
|
| 100MG | 105 | Get Quote |
|
| 500MG | 257 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(±)-Acetylcarnitine chloride
-
NoteResearch use only, not for human use.
-
Brief Description(±)-Acetylcarnitine chloride (Acetyl dl-carnitine chloride) is a weak cholinergic agonist with neuroprotective properties and can be used in studies of neuritis.
-
Description(±)-Acetylcarnitine chloride (Acetyl dl-carnitine chloride) is a weak cholinergic agonist with cholinergic properties. (±)-Acetylcarnitine chloride is an important intermediate in lipid metabolism.
-
In VitroLarge increases of Acetylcarnitine concentration during the flight of the blowfly and the presence of an active Acetylcarnitine transferase indicate that Acetylcarnitine is important in carbohydrate metabolism. Acetylcarnitine has been synthesized by the choline acetylase system isolated from brain tissue and is destroyed by cholinesterase.
-
In VivoIn rats, the infusion of 2 mg (±)-Acetylcarnitine chloride decreases blood flow through the hind limb vasculature 50%. (±)-Acetylcarnitine chloride also potentiates the inhibitory effect of adrenaline on the isolated rabbit duodenum.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2504-11-2
-
Formula Weight239.7
-
Molecular FormulaC9H18ClNO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (417.19 mM; Ultrasonic)
-
SMILES[Cl-].O=C(OC(CC(=O)O)C[N+](C)(C)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. R A Chalmers, et al. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr Res. 1984 Dec;18(12):1325-8.?
molnova catalog
related products
-
PHA 543613
PHA 543613 is a specific agonist of α7 nAChR (Ki = 8.8 nM) and can be used in studies about the cognitive deficits of Alzheimer's disease and schizophrenia.
-
Velufenacin
Velufenacin is an antagonist of muscarinic receptor.
-
SCH-900271
SCH-900271 is a potent nicotinic acid receptor for the treatment of dyslipidaemia and is commonly used in the study of mixed hyperlipidaemia and primary hypercholesterolaemia.
Cart
sales@molnova.com